These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16408496)

  • 1. [Advances in regenerative medicine for skin].
    Kuroyanagi Y
    Nihon Ronen Igakkai Zasshi; 2005 Nov; 42(6):609-15. PubMed ID: 16408496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regenerative medicine for skin].
    Kuroyanagi Y
    Nihon Ronen Igakkai Zasshi; 2006 May; 43(3):326-9. PubMed ID: 16813088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts.
    Kuroyanagi Y; Yamada N; Yamashita R; Uchinuma E
    Artif Organs; 2001 Mar; 25(3):180-6. PubMed ID: 11284884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of banking system for allogeneic cultured dermal substitute.
    Kuroyanagi Y; Kubo K; Matsui H; Kim HJ; Numari S; Mabuchi Y; Kagawa S
    Artif Organs; 2004 Jan; 28(1):13-21. PubMed ID: 14720283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.
    Moroi Y; Fujita S; Fukagawa S; Mashino T; Goto T; Masuda T; Urabe K; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y; Furue M
    Eur J Dermatol; 2004; 14(3):172-6. PubMed ID: 15246944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regenerative medicine for skin].
    Kuroyanagi Y
    Nihon Rinsho; 2003 Mar; 61(3):427-31. PubMed ID: 12701169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.
    Tanaka M; Nakakita N; Kuroyanagi Y
    J Biomater Sci Polym Ed; 1999; 10(4):433-53. PubMed ID: 10227466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.
    Yonezawa M; Tanizaki H; Inoguchi N; Ishida M; Katoh M; Tachibana T; Miyachi Y; Kubo K; Kuroyanagi Y
    Int J Dermatol; 2007 Jan; 46(1):36-42. PubMed ID: 17214717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor.
    Kuroyanagi M; Yamamoto A; Shimizu N; Ishihara E; Ohno H; Takeda A; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2014; 25(11):1133-43. PubMed ID: 24890602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cultured skin substitute composed of fibroblasts and keratinocytes with a collagen matrix: preliminary results of clinical trials.
    Kuroyanagi Y; Kenmochi M; Ishihara S; Takeda A; Shiraishi A; Ootake N; Uchinuma E; Torikai K; Shioya N
    Ann Plast Surg; 1993 Oct; 31(4):340-9; discussion 349-51. PubMed ID: 8239435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts.
    Kubo K; Kuroyanagi Y
    J Artif Organs; 2003; 6(2):138-44. PubMed ID: 14598115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix.
    Yamada N; Uchinuma E; Kuroyanagi Y
    Scand J Plast Reconstr Surg Hand Surg; 1999 Jun; 33(2):147-54. PubMed ID: 10450570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.
    Hasegawa T; Suga Y; Mizoguchi M; Muramatsu S; Mizuno Y; Ogawa H; Kubo K; Kuroyanagi Y
    J Dermatol; 2005 Sep; 32(9):715-20. PubMed ID: 16361714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Engineered Skin Substitutes.
    Goodarzi P; Falahzadeh K; Nematizadeh M; Farazandeh P; Payab M; Larijani B; Tayanloo Beik A; Arjmand B
    Adv Exp Med Biol; 2018; 1107():143-188. PubMed ID: 29855826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-thickness skin wound healing using autologous keratinocytes and dermal fibroblasts with fibrin: bilayered versus single-layered substitute.
    Idrus RB; Rameli MA; Low KC; Law JX; Chua KH; Latiff MB; Saim AB
    Adv Skin Wound Care; 2014 Apr; 27(4):171-80. PubMed ID: 24637651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-engineered skin. Current status in wound healing.
    Bello YM; Falabella AF; Eaglstein WH
    Am J Clin Dermatol; 2001; 2(5):305-13. PubMed ID: 11721649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of a cryopreserved cultured dermal substitute composed of hyaluronic acid and collagen to release angiogenic cytokine.
    Sawa M; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2013; 24(2):224-38. PubMed ID: 23565599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation.
    Kubo K; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2003; 14(7):625-41. PubMed ID: 12903732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute.
    Kashiwa N; Ito O; Ueda T; Kubo K; Matsui H; Kuroyanagi Y
    Artif Organs; 2004 May; 28(5):444-50. PubMed ID: 15113338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dermal-epidermal skin equivalents ('composite-skin') of human keratinocytes in a collagen-glycosaminoglycan matrix(Integra artificial skin).
    Kremer M; Lang E; Berger AC
    Br J Plast Surg; 2000 Sep; 53(6):459-65. PubMed ID: 10927672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.